Bausch + Lomb Turns To Familiar Face As CEO, Brent Saunders
Executive Summary
Saunders will oversee the consumer health, pharma and medtech eye health and vision care specialist, returning to where he got his start as a chief executive before earning a reputation as one of industry’s biggest dealmakers.
You may also be interested in...
With ‘Roadmap To Accelerate Growth,’ Saunders Quick Out Of Gate In Return To Bausch + Lomb
“Multi-year plan with three phases, all with measurable, clear objectives” starts with “rewire company for optimal performance” before moving to “innovate and execute” and then to “accelerate growth,” CEO says.
HBW Executive Decisions: B+L Leadership Changes; CHPA Promotions; ANH Founder’s Larger Role
Bausch + Lomb CEO brings on colleagues from Allergan; American Herbalists Guild executive director receives ABC award; Joseph Betz joins ABC board of trustees; senior management changes in CHPA communications, foundation; ANH founder Ververk takes US helm, too.
HBW Executive Decisions: CDER Compliance Director, CRN Communications VP, Bayer, B+L CEOs
CDER Compliance director Furman no longer acting; former FDA communications director joins CRN; USANA marketing chief On Utah Business’s List; FTC launches Technology Office; and Bayer and Bausch + Lomb appoint CEOs.